|
Gender (% female)
|
73.5
|
50.8
|
48.0
|
|
Age
| | | |
|
18-34
|
0.3
|
1.7
|
0.5
|
|
35-44
|
0.8
|
5.9
|
3.7
|
|
45-54
|
1.0
|
14.3
|
13.2
|
|
55-64
|
3.3
|
26.3
|
29.4
|
|
65-74
|
16.8
|
26.1
|
30.6
|
|
75 and older
|
77.9
|
25.7
|
22.5
|
|
Urbanisation
| | | |
|
2500 or more addresses per square km
|
27.0
|
26.5
|
13.2
|
|
1500-2499 addresses per square km
|
20.9
|
27.3
|
31.8
|
|
1000-1499 addresses per square km
|
20.9
|
21.8
|
13.3
|
|
500-999 addresses per square km
|
14.5
|
11.3
|
15.7
|
|
<500 addresses per square km
|
16.8
|
13.1
|
26.0
|
|
Main medication
| | | |
|
No medication
|
16.0
|
32.3
|
25.1
|
|
Oral medication only
|
61.3
|
54.6
|
61.6
|
|
Oral medication and insulin
|
22.7
|
13.1
|
13.3
|
|
Related comorbidity
| | | |
|
Heart diseases
|
21.4
|
10.5
|
15.2
|
|
Stroke
|
10.7
|
3.3
|
3.2
|
|
Retinopathy
|
1.0
|
0.5
|
0.6
|
|
Nephropathy
|
6.6
|
1.9
|
2.6
|
|
Diabetic foot
|
2.8
|
2.1
|
1.8
|
|
Non-related comorbidity
| | | |
|
Depression
|
8.7
|
3.9
|
4.3
|
|
Lung diseases
|
18.1
|
9.0
|
12.0
|
|
Musculoskeletal diseases
|
36.4
|
27.0
|
28.0
|
|
Neurological diseases
|
2.0
|
1.2
|
1.1
|
|
Cancer
|
8.1
|
3.7
|
3.4
|
